3DSH image
Deposition Date 2008-07-12
Release Date 2008-10-07
Last Version Date 2024-02-21
Entry Detail
PDB ID:
3DSH
Title:
Crystal structure of dimeric interferon regulatory factor 5 (IRF-5) transactivation domain
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Interferon regulatory factor 5
Gene (Uniprot):IRF5
Mutations:S430D
Chain IDs:A
Chain Length:246
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5.
Nat.Struct.Mol.Biol. 15 1213 1220 (2008)
PMID: 18836453 DOI: 10.1038/nsmb.1496

Abstact

Interferon regulatory factors (IRFs) are essential in the innate immune response and other physiological processes. Activation of these proteins in the cytoplasm is triggered by phosphorylation of serine and threonine residues in a C-terminal autoinhibitory region, which stimulates dimerization, transport into the nucleus, assembly with the coactivator CBP/p300 and initiation of transcription. The crystal structure of the transactivation domain of pseudophosphorylated human IRF5 strikingly reveals a dimer in which the bulk of intersubunit interactions involve a highly extended C-terminal region. The corresponding region has previously been shown to block CBP/p300 binding to unphosphorylated IRF3. Mutation of key interface residues supports the observed dimer as the physiologically activated state of IRF5 and IRF3. Thus, phosphorylation is likely to activate IRF5 and other family members by triggering conformational rearrangements that switch the C-terminal segment from an autoinihibitory to a dimerization role.

Legend

Protein

Chemical

Disease

Primary Citation of related structures